Skip to main content
YUHAN CORPORATION logo

YUHAN CORPORATION — Investor Relations & Filings

Ticker · 000100 ISIN · KR7000100008 KO Manufacturing
Open in API
Filings indexed 635 across all filing types
Latest filing 2025-03-12 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 000100

About YUHAN CORPORATION

http://eng.yuhan.co.kr

Yuhan Corporation, established in 1926, is an integrated healthcare company engaged in the discovery, development, manufacturing, and marketing of pharmaceutical products. Its diverse portfolio encompasses prescription drugs, over-the-counter (OTC) medications, Active Pharmaceutical Ingredients (APIs), and intermediates for various therapeutic areas, including antibiotics and antivirals. The company also produces veterinary drugs and household goods. In addition to its own product lines, Yuhan operates as a Contract Development and Manufacturing Organization (CDMO), offering comprehensive services to the pharmaceutical sector. Through its affiliates, the company is also involved in specialized areas such as nutrient infusion solutions.

Recent filings

Filing Released Lang Actions
사업보고서 (2024.12)
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive 'Consolidated Audit Report' (연결감사보고서) for Yuhan Corporation, covering the fiscal years 2023 and 2024. It includes the independent auditor's report, consolidated financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes. As it contains full financial statements and audit opinions for a specific period, it is classified as an Interim/Quarterly Report (IR) or, in this case, the annual financial reporting package which falls under the IR category in the provided schema for comprehensive financial reports. FY 2024
2025-03-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details the share transactions (specifically an 'on-market purchase' or 장내매수) by an executive (CEO Cho Wook-je) of Yuhan Corporation. This type of filing is a standard disclosure for insider trading/director dealings.
2025-03-11 Korean
투자판단관련주요경영사항
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from Yuhan Corporation regarding the termination of a technology transfer agreement for a NASH treatment. It details the cancellation of a contract with Boehringer Ingelheim, the financial impact (non-refundable milestone payments), and the date of notification. This falls under 'Regulatory Filings' (RNS) as it is a specific corporate disclosure of a material event that does not fit into more specialized categories like M&A (which usually implies a merger or acquisition of a company) or legal proceedings (which usually implies litigation).
2025-03-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an executive (Cho Wook-je) of Yuhan Corporation. This type of filing is a standard regulatory requirement for reporting insider transactions (purchases or sales of company shares by directors/executives). In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS).
2025-02-28 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Yuhan Corporation. It contains the agenda for the 102nd Annual General Meeting, including reports on financial statements, board activities, and proposed resolutions. This document is a standard proxy solicitation and information statement provided to shareholders to inform them of the meeting details and agenda items, which falls under the 'Proxy Solicitation & Information Statement' category.
2025-02-19 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document) and is issued by Yuhan Corporation. It contains information regarding the upcoming Annual General Meeting (AGM), including the purpose of the meeting, voting procedures, and detailed financial statements (balance sheet, income statement, etc.) for the fiscal year 2024. This document is a formal proxy solicitation material sent to shareholders to request their votes for the AGM, which falls under the 'Proxy Solicitation & Information Statement' category.
2025-02-19 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.